It’s not just another health care technology but a totally new way of operating that touches all stakeholders in a profound way. Almost 250 million people have downloaded at least one mobile health app, while 50% of doctors use smartphones for the job.
The CEO of the Cleveland Clinic explains what makes this highly respected hospital system so good that it’s success is being exported. Innovative methods pertaining to, for instance, physician engagement are about to go international, with the opening of satellites in Canada and even the United Arab Emirates.
How to keep up with the development of hundreds of new and emerging drugs, devices, and procedures? The Agency for Healthcare Quality offers horizon scanning, in which it tracks emerging technologies and services in clinical stages of research, or very early adoption.
This long-standing method of documentation is being used in new and interesting ways. Blue Cross Blue Shield of Michigan, for instance, finds that if you let the providers own the data, they’ll get all the motivation they need to improve outcomes.
A few pilots throughout the country show the promise of bundled payment programs. But in order for them to work, contracts between providers and insurers need to be fair, open, detailed and clear. In other words, it takes true collaboration.
“What’s a reasonable cost?” asks Richard Schilsky, MD, the CMO of the American Society of Clinical Oncology. “A hundred thousand for a few months of life?” Such are the tough questions presented by cutting-edge treatments: questions that can’t be ignored. Oncologists lead a national conversation.
For instance, obinutuzumab (which is getting closer to market) not only attacks cancer cells with the CD20 marker, but it is engineered to stimulate the body’s immune system into fighting those cells as well. To be used for patients with chronic lymphocytic leukemia.
State lawmakers want hospitals to reveal what they’ve negotiated with health plans for lists of services that grow ever longer
Michael Hogue, PharmD
Pharmacists have long wanted more opportunities to contribute and to be respected for their abilities. Behold the patient-centered medical home.
Robert Royce, PhD
The United Kingdom’s debate about linking health with social services tackles a problem that is also a concern in the United States
Thomas Morrow, MD
This cutting-edge method of matching drugs to patient may eventually be used for cystic fibrosis, cancer, and autoimmune diseases